Peripheral Neuropathies
Toxic peripheral neuropathies
Apr. 01, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Index patient presenting with hypotonia, a developmental delay, at the age of 19 months. Bilateral humerus fractures at birth should be noted. He had a previous diagnosis of osteogenesis imperfecta. He had a facial weakness, myopathic face, and involvement of neck flexor muscles with head-lag, and his maximum motor capacity is to sit without support. He is unable to stand on his feet. The following are pictures of the patient: (a) patient at the age of 4 years unable to walk; (b) muscle biopsy at the age of 19 months, demonstrating myopathic changes with increased fatty and fibrous tissue infiltration (HE); (c) central cores (NADH); and (d) index patient carrying a recessive RYR1 mutation; his father carrying a dominant RYR1-malignant hyperthermia susceptibility mutation. (Courtesy of Dr. Goknur Haliloglu.)